COVID-19: the use of immunotherapy in metastatic lung cancer

Alexander P. Davis, Michael Boyer, Jenny H. Lee, Steven C. Kao*

*Corresponding author for this work

Research output: Contribution to journalComment/opinionpeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)545-548
Number of pages4
JournalImmunotherapy
Volume12
Issue number8
DOIs
Publication statusPublished - Jun 2020

Keywords

  • COVID-19
  • duration of therapy
  • immune checkpoint inhibitors
  • immunotherapy
  • lung cancer

Cite this